Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 209 for:    Ovarian Dysgenesis 1

AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00770536
Recruitment Status : Completed
First Posted : October 10, 2008
Last Update Posted : September 29, 2015
Sponsor:
Information provided by (Responsible Party):
Amgen

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 2012
Actual Study Completion Date : June 2015